Recent findings demonstrated that the administration of 5-caffeoylquinic acid can normalize Aqp4 perivascular mislocalization and increase Aβ clearance in an APP/PS2 AD mouse model, which improved cognitive deficits and neuronal functions [38]. This evidence concerns the gene AQP4 and Alzheimer disease.